Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
Bilateral Poorly Differentiated Adenocarcinoma of the Lacrimal Gland With Tumor Regression After Treatment With Pembrolizumab.
Journal: Ophthalmic plastic and reconstructive surgery
Published: April 14, 2020
A phase 2 study of glembatumumab vedotin, an antibody-drug conjugate targeting glycoprotein NMB, in patients with advanced melanoma.
Journal: Cancer
Published: June 05, 2018
Showing 1-2 of 2
Last Updated: 09/26/2026